SE426237B - Forfarande for framstellning av nya bensofenonderivat - Google Patents

Forfarande for framstellning av nya bensofenonderivat

Info

Publication number
SE426237B
SE426237B SE7606707A SE7606707A SE426237B SE 426237 B SE426237 B SE 426237B SE 7606707 A SE7606707 A SE 7606707A SE 7606707 A SE7606707 A SE 7606707A SE 426237 B SE426237 B SE 426237B
Authority
SE
Sweden
Prior art keywords
procedure
preparing new
benzophenon
derivatives
benzophenon derivatives
Prior art date
Application number
SE7606707A
Other languages
English (en)
Other versions
SE7606707L (sv
Inventor
B Basil
K R H Woolbridge
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of SE7606707L publication Critical patent/SE7606707L/sv
Publication of SE426237B publication Critical patent/SE426237B/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/32Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/54Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition of compounds containing doubly bound oxygen atoms, e.g. esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7606707A 1975-06-20 1976-06-11 Forfarande for framstellning av nya bensofenonderivat SE426237B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB26407/75A GB1495680A (en) 1975-06-20 1975-06-20 1-(2-benzoylphenoxy)-2-hydroxy-3-aminopropanes

Publications (2)

Publication Number Publication Date
SE7606707L SE7606707L (sv) 1976-12-21
SE426237B true SE426237B (sv) 1982-12-20

Family

ID=10243171

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7606707A SE426237B (sv) 1975-06-20 1976-06-11 Forfarande for framstellning av nya bensofenonderivat

Country Status (13)

Country Link
JP (1) JPS525749A (sv)
AU (1) AU503182B2 (sv)
BE (1) BE843170A (sv)
CH (1) CH601186A5 (sv)
DE (1) DE2627210A1 (sv)
DK (1) DK145041C (sv)
FR (1) FR2314711A1 (sv)
GB (1) GB1495680A (sv)
IE (1) IE43119B1 (sv)
LU (1) LU75199A1 (sv)
NL (1) NL7606354A (sv)
SE (1) SE426237B (sv)
ZA (1) ZA763514B (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1147311B (it) * 1980-02-13 1986-11-19 Stabil Bioterapico Farmachim Eteri basici di 4-idrossi-benzofenoni con attivita' quali agenti betabloccanti e relativi procedimento di preparazione
SE9101509D0 (sv) * 1991-05-17 1991-05-17 Karobio Ab Receptor ligands

Also Published As

Publication number Publication date
NL7606354A (nl) 1976-12-22
IE43119B1 (en) 1980-12-17
DK145041B (da) 1982-08-09
DE2627210A1 (de) 1976-12-30
GB1495680A (en) 1977-12-21
FR2314711B1 (sv) 1978-12-15
SE7606707L (sv) 1976-12-21
DK262776A (da) 1976-12-21
AU503182B2 (en) 1979-08-23
DK145041C (da) 1983-01-10
FR2314711A1 (fr) 1977-01-14
IE43119L (en) 1976-12-20
CH601186A5 (sv) 1978-06-30
AU1491076A (en) 1977-12-22
BE843170A (fr) 1976-12-20
LU75199A1 (sv) 1977-03-15
ZA763514B (en) 1977-05-25
JPS525749A (en) 1977-01-17

Similar Documents

Publication Publication Date Title
SE434394B (sv) Analogiforfarande for framstellning av kinolonalkansyraderivat
SE7610422L (sv) Forfarande for framstellning av pyrimidinderivat
SE445923B (sv) Forfarande for framstellning av glukosaminderivat
SE431089B (sv) Forfarande for framstellning av beta-metyltio-propionaldehyd
SE434057B (sv) Forfarande for framstellning av nya rifamycinforeningar
SE442400B (sv) Forfarande for framstellning av nya 1-aryloxi-2-hydroxi-3-alkylenaminopropaner
SE440772B (sv) Forfarande for framstellning av nya 1-naftylmetyl-cinnamyl-aminderivat
SE420201B (sv) Forfarande for framstellning av nya 7alfa-metoxicefalosporinderivat
SE7600139L (sv) Nya vifenyloxiderivat
SE422065B (sv) Forfarande for framstellning av nya derivat av tiazolo-(3,4-b)-isokinolin
SE433745B (sv) Forfarande for framstellning av tetrahydroisokinolinderivat
SE7704545L (sv) Forfarande for framstellning av nya adeninderivat
SE424553B (sv) Forfarande for framstellning av nya indazol-derivat
SE7613768L (sv) Forfarande for framstellning av penicillinestrar
SE423390B (sv) Foerfarande foer framstaellning av eburnameninderivat
SE428296B (sv) Analogiforfarande for framstellning av substituerade difonylsulfider
SE433220B (sv) Forfarande for framstellning av nya pregnan-derivat
SE431539B (sv) Analogiforfaranden for framstellning av nya bensylalkoholderivat
SE423902B (sv) Forfarande for framstellning av purinderivat
SE420493B (sv) Forfarande for framstellning av nya xantinderivat
SE439159B (sv) Forfarnde for framstellning av nya 5-fluoropyrimidin-4-on-derivat
SE440903B (sv) Forfarande for framstellning av nya 1-aryloxi-2-hydroxi-3-aminopropaner
SE422794B (sv) Forfarande for framstellning av basiskt substituerade naftalenderivat
SE433210B (sv) Forfarande for framstellning av ny cyklohexylfenylderivat
SE7612565L (sv) Forfarande for framstellning av nya rifamycinforeningar